The $30 Lab Test Your PCOS Patients Desperately Need
And why most of them aren’t getting it.
By Herm Weiss, MD, MBA, FACOG | @hweissmd
Let me paint you a picture.
A 27-year-old woman walks into your office. Irregular periods since menarche. A little extra hair where she doesn’t want it. Blood sugar creeping up. She’s been told she has PCOS. She’s been handed a metformin prescription and a pamphlet about “lifestyle modification.” She has done everything right — cleaner diet, more exercise, less stress (ha) — and she still feels like her body is working against her.
You order the standard workup. LH/FSH. Testosterone. Fasting insulin. Pelvic ultrasound.
Did you order a 25-hydroxyvitamin D level?
If the answer is no — and statistically, it often is — keep reading. Because the literature is telling us something we’ve been collectively slow to act on, and our patients are paying the price.
PCOS Is Not Just a Hormonal Problem. It’s a Metabolic One.
PCOS affects between 4 and 20% of reproductive-age women worldwide, making it the most prevalent endocrine disorder in this population. That’s not a niche diagnosis — that’s an epidemic hiding in plain sight.
What we often underemphasize in clinical practice is how profoundly metabolic PCOS is. Visceral obesity, hyperinsulinemia, insulin resistance, dyslipidemia, elevated cardiovascular risk, and increased rates of endometrial carcinoma — PCOS is a syndrome that reaches far beyond the ovary. And at the center of many of these metabolic disturbances sits a single, chronically underappreciated variable: Vitamin D.
Why Vitamin D Is Not “Just a Bone Vitamin”
Let’s be precise about the biology here, because the word “vitamin” undersells what we’re actually talking about. Vitamin D is a steroid hormone. It operates through nuclear receptors — Vitamin D receptors (VDRs) — that are expressed in tissues throughout the body, including the granulosa cells of the ovary, the cumulus oophorus, the decidua, the placenta, and vascular endothelium.
Active Vitamin D (1,25-dihydroxyvitamin D3) regulates the expression of hundreds of genes — including several directly relevant to glucose homeostasis, steroidogenesis, and folliculogenesis. There is a documented Vitamin D response element on the promoter region of the human insulin receptor gene. This is not soft science. This is molecular endocrinology telling us that Vitamin D has a direct mechanistic role in insulin signaling.
When your patient is deficient — and in PCOS, deficiency is the rule, not the exception — you’re not just dealing with suboptimal bone density. You’re dealing with impaired insulin receptor expression, disrupted follicular development, dysregulated AMH, elevated androgens, and a reproductive system that is, in biochemical terms, running on fumes.
The Vitamin D–PCOS Connection: What the Data Shows
The association between Vitamin D deficiency and PCOS has been documented across multiple domains:
Reproductive function. VDRs are present throughout the female reproductive tract. Active Vitamin D regulates anti-Müllerian hormone (AMH) expression in granulosa cells — a critical marker of ovarian reserve and PCOS severity. Women with PCOS consistently show lower follicular fluid Vitamin D levels compared to non-PCOS women. Vitamin D supplementation has been shown to decrease elevated serum AMH, improve folliculogenesis, lower serum testosterone, and normalize menstrual cycles in a meaningful proportion of patients.
In one frequently cited study, seven of nine oligomenorrheic PCOS women who received Vitamin D and calcium supplementation had their menstrual cycles normalize within months. Two became pregnant. This wasn’t a drug trial. This was supplementation of a deficiency.
In a larger study of 57 women with PCOS given 20,000 IU of Vitamin D weekly for 24 weeks, half of those who were oligo-amenorrheic at baseline reported improved menstrual regularity at 24 weeks. Four of the sixteen women attempting conception during the study conceived.
Insulin resistance. The link between Vitamin D and insulin sensitivity is arguably the most robust in this literature. Vitamin D enhances insulin receptor expression, activates transcription of the insulin gene, and reduces pro-inflammatory cytokines — all of which improve glucose metabolism. Meta-analyses of randomized controlled trials support the conclusion that Vitamin D supplementation at doses below 4,000 IU/day improves insulin resistance and fasting glucose in Vitamin D-deficient women with PCOS. The relationship between Vitamin D deficiency and insulin resistance in PCOS appears to be independent of BMI — meaning your lean PCOS patients are not off the hook.
Cardiovascular risk. PCOS carries an increased burden of cardiovascular risk factors: elevated total cholesterol, triglycerides, systolic and diastolic blood pressure, and C-reactive protein. VDRs are expressed in vascular smooth muscle and endothelium. Large cohort studies have established an inverse relationship between Vitamin D levels and cardiovascular disease risk — and this association holds in PCOS women specifically.
Mental health. This one gets overlooked almost entirely in clinical practice. Low 25(OH)D levels have been associated with mood disorders including major depressive disorder, premenstrual syndrome, and seasonal affective disorder. PCOS itself carries significant psychological burden — depression, anxiety, body image disturbance. The hormonal and neurotransmitter pathways that mediate the psychological response to PCOS symptoms may be directly modulated by Vitamin D status. Treating the deficiency is not going to cure depression. But ignoring it isn’t helping.
Genetic susceptibility. VDR polymorphisms — including Apa-I, Taq-I, Cdx2, Bsm-I, and Fok-I — have been linked to the metabolic phenotype of PCOS. Specific genotypes are associated with higher LH levels, lower SHBG, worse insulin sensitivity, and greater hyperandrogenemia. This means some patients are genetically predisposed to both Vitamin D dysregulation and PCOS severity — making assessment and correction not optional, but foundational to their management.
What Does This Mean Clinically?
First: check the level. A serum 25(OH)D is inexpensive, widely available, and actionable. The threshold for sufficiency is generally defined as ≥30 ng/mL, though emerging evidence suggests optimal metabolic function may require levels closer to 40–60 ng/mL. Many PCOS patients will come in well below 20.
Second: correct it meaningfully. Maintenance doses of 1,500–2,000 IU/day are often insufficient for true repletion in deficient patients. Depending on the baseline level, you may need to prescribe 4,000–5,000 IU/day with or without a loading protocol. Add calcium supplementation in patients with low dietary intake — several studies used the combination of Vitamin D plus calcium, and the synergy matters.
Third: reassess. Check levels again at 3 months. Adjust. Monitor. This is not a one-and-done intervention.
Fourth: contextualize expectations. Vitamin D supplementation is not a PCOS cure. It is a necessary, evidence-supported component of a comprehensive management strategy. The patients most likely to benefit from targeted Vitamin D correction are those with clear deficiency, insulin resistance as a dominant feature, menstrual irregularity, and fertility concerns. The data on dyslipidemia improvement, while statistically significant in meta-analyses, has not yet been confirmed in large-scale clinical trials — so temper the conversation accordingly.
The Bottom Line
We spend considerable time, effort, and patient money on sophisticated PCOS workups. We debate metformin versus inositol versus GLP-1 receptor agonists. We discuss ovulation induction protocols and IVF candidacy.
And sometimes we miss a $30 lab test.
The relationship between Vitamin D and PCOS is not a fringe hypothesis. It is supported by mechanistic data, observational studies, pilot trials, and meta-analyses spanning reproductive, metabolic, cardiovascular, and psychiatric outcomes. The evidence base has limitations — most studies are small, many lack robust placebo controls, and we still need large-scale RCTs to define optimal dosing protocols. But the risk profile of correcting a documented deficiency is negligible. The potential upside, particularly for menstrual regularity, insulin sensitivity, and fertility, is real.
Check the level. Correct the deficiency. Reassess.
Your PCOS patients deserve a complete workup — and Vitamin D belongs in it.
Herm Weiss, MD, MBA, FACOG is an OB/GYN with 25 years of clinical experience and CEO of Provation Life, a women’s metabolic health company. This post is for educational purposes and does not constitute individual medical advice.
Primary source: Mohan A, et al. Vitamin D and polycystic ovary syndrome (PCOS): a review. Annals of Medicine & Surgery (2023) 85:3506–3511.
Medical Disclaimer
The information provided in this blog post and newsletter is for educational and informational purposes only. It does not constitute medical advice or professional services and should not be used to diagnose or treat any health problem or disease. Always seek the advice of your physician or other qualified health‑care provider regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read here.
Use of this content does not create a doctor–patient relationship. Individual responses to treatments and lifestyle changes can vary, and only your healthcare provider can evaluate your specific circumstances. If you are experiencing a medical emergency, call your local emergency services immediately.
Subscribe to @hweissmd on Substack for evidence-based women’s health — no fluff, no fads.